ATE172638T1 - Ein neues arzneimittelabgabesystem - Google Patents

Ein neues arzneimittelabgabesystem

Info

Publication number
ATE172638T1
ATE172638T1 AT95924940T AT95924940T ATE172638T1 AT E172638 T1 ATE172638 T1 AT E172638T1 AT 95924940 T AT95924940 T AT 95924940T AT 95924940 T AT95924940 T AT 95924940T AT E172638 T1 ATE172638 T1 AT E172638T1
Authority
AT
Austria
Prior art keywords
pct
delivery system
drug delivery
date jan
sec
Prior art date
Application number
AT95924940T
Other languages
English (en)
Inventor
Paolo Alberto Veronesi
Original Assignee
Therapicon Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therapicon Srl filed Critical Therapicon Srl
Application granted granted Critical
Publication of ATE172638T1 publication Critical patent/ATE172638T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
AT95924940T 1994-07-11 1995-06-24 Ein neues arzneimittelabgabesystem ATE172638T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9413951A GB2290965A (en) 1994-07-11 1994-07-11 Multiple layer capsules for drugs

Publications (1)

Publication Number Publication Date
ATE172638T1 true ATE172638T1 (de) 1998-11-15

Family

ID=10758141

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95924940T ATE172638T1 (de) 1994-07-11 1995-06-24 Ein neues arzneimittelabgabesystem

Country Status (12)

Country Link
US (1) US5814338A (de)
EP (1) EP0769938B1 (de)
JP (1) JPH10502376A (de)
KR (1) KR100381208B1 (de)
AT (1) ATE172638T1 (de)
AU (1) AU707076B2 (de)
CA (1) CA2194890A1 (de)
DE (2) DE69505671T2 (de)
ES (1) ES2104522T3 (de)
GB (1) GB2290965A (de)
WO (1) WO1996001612A1 (de)
ZA (1) ZA955741B (de)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9426079D0 (en) * 1994-12-23 1995-02-22 Orion Yhtymae Oy A gelatine capsule
US5708017A (en) * 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
WO1996040083A2 (en) * 1995-06-07 1996-12-19 R.P. Scherer Corporation Methods and compositions for preparing soft gelatin capsules having shells resistant to permeation by fill materials
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
IT1293835B1 (it) * 1997-08-08 1999-03-10 Foscama Biomed Chim Farma Composizioni farmaceutiche orali in forma solida a cessione modulata contenenti nicorandil e procedimento per la loro preparazione
US6531150B1 (en) * 1997-10-30 2003-03-11 Morishita Jintan Co., Ltd. Encapsulated unsaturated fatty acid substance and method for producing the same
NL1009107C2 (nl) * 1997-11-12 1999-06-15 Banner Pharmacaps Inc Gelatine-uitspreidende doos met meervoudige, aanpasbare poortklep en meerlagig zacht gel.
US6096340A (en) 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
IL136285A0 (en) * 1997-12-08 2001-05-20 Byk Gulden Lomberg Chem Fab Pharmaceutical compositions containing an acid-labile active component
DE19801811B4 (de) * 1998-01-19 2004-12-23 Stada Arzneimittel Ag Pharmazeutische Zubereitung zur oralen Verabreichung
DE19814257A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
ATE404172T1 (de) 1998-12-30 2008-08-15 Dexcel Ltd Dispergierbares konzentrat zur verabreichung von cyclosporin
JP4854115B2 (ja) * 1999-03-12 2012-01-18 エイシカ ファーマシューティカルス リミテッド 無水パロキセチン用安定製剤形
FR2793688B1 (fr) 1999-05-21 2003-06-13 Ethypharm Lab Prod Ethiques Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
US6423746B1 (en) * 1999-07-03 2002-07-23 The William M. Yarbrough Foundation Urushiol induced contact dermatitis and method of use
DE69907479T2 (de) * 1999-12-16 2004-04-08 Laboratorio Medinfar-Produtos Farmacéuticos, S. A. Piroxicam enthaltende gastrointestinale Zubereitung aus merheren Einheiten bestehend
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
GB2398499B (en) * 2000-02-16 2004-11-24 Bioprogress Technology Ltd Two layer capsules
US6365181B1 (en) 2000-04-20 2002-04-02 Gattefosse Corporation Thixatropic gelatin carrier composition
US6306435B1 (en) 2000-06-26 2001-10-23 Yung Shin Pharmaceutical Industrial Co. Ltd. Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same
ITMI20011401A1 (it) * 2001-07-02 2003-01-02 Altergon Sa Formulazioni farmaceutiche per ormoni tiroidei
AR034813A1 (es) * 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
WO2003063840A2 (en) * 2002-01-25 2003-08-07 Santarus, Inc. Transmucosal delivery of proton pump inhibitors
GB0203296D0 (en) 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
US8168170B2 (en) 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
MY148805A (en) * 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
WO2004073654A2 (en) * 2003-02-20 2004-09-02 Santarus, Inc. A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained supression of gastric acid
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US7247010B2 (en) * 2003-10-01 2007-07-24 Technophar Equipment & Service Limited Servo control for capsule making machine
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
US20050118124A1 (en) * 2003-12-01 2005-06-02 Reinhart Gale M. Compositions for treating keratinous surfaces
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2805537C (en) * 2004-11-02 2015-02-10 Machine Solutions, Inc. Stent sheathing technology
EP2261323A1 (de) 2005-05-31 2010-12-15 The Iams Company Probiotische Katzen-Laktobazillen
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
PT1931346E (pt) 2005-09-09 2012-08-14 Angelini Labopharm Llc Composição de trazodona para administração uma vez por dia
WO2007048219A2 (en) 2005-09-09 2007-05-03 Labopharm Inc. Sustained drug release composition
US8298602B2 (en) * 2005-10-11 2012-10-30 Purecircle Sdn Bhd Process for manufacturing a sweetener and use thereof
US20070203040A1 (en) * 2006-02-24 2007-08-30 Harry Reicherz Bar soap
CA2654402A1 (en) * 2006-06-01 2007-12-06 Adel Penhasi Multiple unit pharmaceutical formulation
JP5233108B2 (ja) * 2006-10-24 2013-07-10 ゼリア新薬工業株式会社 ニザチジン含有医薬組成物
RU2436581C2 (ru) 2007-02-01 2011-12-20 Дзе Иамс Компани Способ уменьшения воспаления и снижения стресса у млекопитающего
US8137598B2 (en) * 2007-03-06 2012-03-20 Kee Action Sports Technology Holdings, Llc Spreader box apparatus and method of forming bi-laminar paintball shell material and paintballs for use with paintball gun
WO2008112227A1 (en) * 2007-03-12 2008-09-18 Reliant Pharmaceuticals, Inc. Treatment with nicorandil and omega-3 fatty acids, and a combination product thereof
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
FR2936952A1 (fr) * 2008-10-09 2010-04-16 Monique Bellec Administration par voie orale de medicaments et complements nutritionnels
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
WO2011050474A1 (en) 2009-10-29 2011-05-05 Acasti Pharma, Inc. Concentrated therapeutic phospholipid compositions
ES2363964B1 (es) 2009-11-20 2012-08-22 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
ES2364011B1 (es) 2009-11-20 2013-01-24 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados para el tratamiento de enfermedades cardiovasculares.
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CN118634202A (zh) 2016-08-05 2024-09-13 帕克治疗公司 室温稳定的口服降钙素制剂
US11298336B2 (en) 2019-05-30 2022-04-12 Soluble Technologies, Inc. Water soluble formulation
US11786475B2 (en) 2020-07-22 2023-10-17 Soluble Technologies Inc. Film-based dosage form
CN113456497B (zh) * 2021-06-25 2025-10-21 上海信谊万象药业股份有限公司 一种软胶囊压丸机胶皮成型与输送系统
JP2025504600A (ja) * 2022-01-24 2025-02-12 オーエフディー バイオファーマ リミテッド ライアビリティ カンパニー 単位剤型形体を製造するための、方法、システム及び材料
WO2025132620A1 (en) 2023-12-20 2025-06-26 Bayer Consumer Care Ag Stable soft capsule preparations with solid fill for moisture sensitive active ingredients
WO2025219169A1 (en) 2024-04-16 2025-10-23 Bayer Consumer Care Ag Stable soft capsule preparations with liquid fill for moisture sensitive active ingredients

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH476499A (de) * 1964-12-31 1969-08-15 Ciba Geigy Mischung zum Überziehen von Rektal-Kapseln
YU36434B (en) * 1969-05-14 1984-02-29 Sanol Arznei Schwarz Gmbh Process for obtaining gelation capsules filled with the active substance resistant to gastric juice and dissolvable in the small intestine
DE2340060A1 (de) * 1973-08-08 1975-02-20 Scherer Gmbh R P Magensaftresistente gelatinekapseln und verfahren zu deren herstellung
DE3437599C2 (de) * 1984-10-13 1987-04-16 Dolorgiet GmbH & Co KG, 5205 St Augustin Ibuprofen enthaltende Weichgelatinekapseln
US4816259A (en) * 1987-02-12 1989-03-28 Chase Chemical Company, L.P. Process for coating gelatin capsules
JPH01232963A (ja) * 1988-03-14 1989-09-18 Arimento Kogyo Kk 重層軟カプセルの製造方法
DE3818022C2 (de) * 1988-05-24 1994-04-28 Guenter Stephan Weichgelatinekapsel
DE3927113C2 (de) * 1989-08-17 1993-11-25 Dolorgiet Gmbh & Co Kg Mittel zur Behandlung von schweren Schmerzzuständen und Verfahren zu ihrer Herstellung
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form

Also Published As

Publication number Publication date
DE769938T1 (de) 1997-09-11
EP0769938A1 (de) 1997-05-02
JPH10502376A (ja) 1998-03-03
ZA955741B (en) 1997-01-07
ES2104522T3 (es) 1999-03-16
ES2104522T1 (es) 1997-10-16
KR970704427A (ko) 1997-09-06
GB9413951D0 (en) 1994-08-31
AU707076B2 (en) 1999-07-01
US5814338A (en) 1998-09-29
DE69505671D1 (de) 1998-12-03
AU2925295A (en) 1996-02-09
KR100381208B1 (ko) 2003-07-18
GB2290965A (en) 1996-01-17
EP0769938B1 (de) 1998-10-28
WO1996001612A1 (en) 1996-01-25
DE69505671T2 (de) 1999-06-10
CA2194890A1 (en) 1996-01-25

Similar Documents

Publication Publication Date Title
DE69505671D1 (de) Ein neues arzneimittelabgabesystem
PT1117386E (pt) Administracao enterica e colonica utilizando capsulas de hpmc
NO995313L (no) Mikroartikler nyttige som ultrasoniske kontrastmidler og til levering av legemidler i blodbanen
DE69820108D1 (de) Doppelkapsel zur verabreichung von arzneimitteln für vielfache therapien
ZA982911B (en) Drug delivery system for two or more active substances
NO922005L (no) Farmasoeytiske preparater
ATE269709T1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
MY112915A (en) Multiple unit tableted dosage form 1
EP0693924A4 (de) Verfahren für die in-vivo-verabreichung von biologischen substanzen und hierfür verwendbare zusammensetzungen
HU9603530D0 (en) Process for producing pharmaceutical compositions containing agent in polymer-matrix and in solid solution form and these medicaments
MA26456A1 (fr) Formulations pharmaceutiques pour la distribution prolongee de medicament.
ATE232100T1 (de) Gegen magensaft geschützte omeprazol- mikrogranülen, herstellungsverfahren und pharmazeutische zubereitungen
DE59604603D1 (de) Arzneiform zur abgabe von wirkstoffen an wunden
FR2778406B1 (fr) Derives d'alpha-cetoamides, procede pour leur preparation, preparations pharmaceutiques les contenant, et leur utilisation en tant que medicaments anti-viraux
DE69825164D1 (de) Arzneizubereitungen enthaltend vitamin d und kalzium,ihre herstellung und therapeutische verwendung
CY1105026T1 (el) Συστημα χορηγησεως φαρμακου : συνθεση δια λιπο-διαλυτα φαρμακα
AR011437A1 (es) Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento.
ATE256134T1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
FR2679777B1 (fr) Microcapsules contenant des substances amphiphiles et hydrosolubles, leur procede de preparation ainsi que leurs applications en chirurgie et en medecine.
SE9503620L (sv) Användning av proteinet S-100b för framställning av läkemedel för nervceller
NO975923L (no) Fremgangsmåte for fremstilling av aktive stoffer fra ubrukte eller avhendede innretninger for transdermal administering av aktive stoffer og/eller fra deres produksjonsavfall
FR2751967B1 (fr) Agents antipaludeens et antibabesioses et compositions pharmaceutiques les contenant
BR9801839A (pt) Medicamento analgésico e aplicação de (+) -0-demetiltramadol.
FR2667066B2 (fr) N-heterocyclyl glycinamides, leur preparation et les medicaments les contenant.
FI962728A0 (fi) Lääkeyhdistelmä yksilöiden riippuvuutta opiaateista ehkäisevänä lääkkeenä

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties